JRS PHARMA LP

JRS PHARMA LP specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production of advanced tablet formulations using proprietary excipient systems such as PROSOLV EASYTAB SP. Their technical capabilities center on solid dosage form development, direct compression processes, and the formulation of high-performance oral solid products optimized for stability, bioavailability, and manufacturability. The contractor leverages precise control over powder flow, compressibility, and disintegration properties to deliver consistent, high-quality tablet products compliant with cGMP standards. Their specialization in PROSOLV EASYTAB SP—a proprietary direct compression excipient system—reflects a focused niche in streamlining tablet manufacturing while maintaining stringent pharmaceutical quality attributes. The company maintains a consistent relationship with the Department of Veterans Affairs, supplying critical pharmaceutical components for veteran healthcare programs. Their work supports the VA’s mission to ensure reliable access to essential medications through the production of standardized, high-integrity oral solid dosage forms used in clinical settings. JRS PHARMA LP operates exclusively within NAICS 325412, positioning itself as a specialized manufacturer in pharmaceutical preparation, specifically focused on advanced tablet technologies. Their market differentiation lies in their command of proprietary excipient systems that enable efficient, scalable production without the need for wet granulation, reducing process complexity and enhancing batch consistency. As a privately held entity structured as a 2K corporation, JRS PHARMA LP is headquartered in Patterson, New York, with no publicly disclosed federal certifications. Their geographic footprint is limited to this facility, where all manufacturing and quality control activities are conducted under strict pharmaceutical regulatory frameworks. The company serves a targeted segment of the federal pharmaceutical supply chain through precision manufacturing rather than broad-scale distribution.